Showing 1 posts of 1 posts found.
Mylan has been under scrutiny over its pricing policy with its branded EpiPen; the pressure told and led to them …
MHRA approves first lower-carbon beclometasone inhalers for asthma
Samsung Biologics launches bid to acquire peptide CDMO PolyPeptide
Novogenia breaks ground on personalised healthcare campus
InfectoPharm launches Polish operations with first hospital antibiotic
FibroFind appoints Lee Borthwick as CEO